Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928195 · ClinicalTrials.gov registry record · NA
Acute Effects of Organic Guayusa Extract
A NA study, sponsored by Nathaniel Jenkins.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05928195 is a NA study that has completed, run by Nathaniel Jenkins. The registered enrollment target is 32 participants.
The verdict
NCT05928195, a NA study, has completed, sponsored by Nathaniel Jenkins.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Guayusa extract is a caffeinated tea leaf unique blend of antioxidants and caffeine. It is marketed as an ingredient that can help support energy and performance with potential health-related benefits. It has also been indicated as being as safe as any other existing teas (i.e., green tea). However, no studies have previous studied the dose-response effects of guayusa extract for supporting cognitive function, mood, metabolism, nor its effects on resting heart rate, blood pressure, and electrocardiogram characteristics.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Acute Moderate-Dose Guayusa Extract Supplementation
- DIETARY_SUPPLEMENT Acute High-Dose Guayusa Extract Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-05-16 |
| Est. Completion | 2023-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05928195
The ClinicalTrials.gov registry entry for NCT05928195 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nathaniel Jenkins, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05928195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05928195 about?
NCT05928195 is a clinical study titled "Acute Effects of Organic Guayusa Extract". Guayusa extract is a caffeinated tea leaf unique blend of antioxidants and caffeine. It is marketed as an ingredient that can help support energy and performance with potential health-related benefits. It has also been indicated as being as safe as any other existing teas (i.e., green tea). However,...
What is the current status of trial NCT05928195?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-05-16. Estimated completion is 2023-04-12.
What interventions are being tested in trial NCT05928195?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Acute Moderate-Dose Guayusa Extract Supplementation (DIETARY_SUPPLEMENT), Acute High-Dose Guayusa Extract Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05928195?
This trial is sponsored by Nathaniel Jenkins, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.